|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Aureus Pharma, of Paris, and ChemAxon, of Budapest, Hungary, were awarded a European Eureka project along with pharmaceutical partner Sanofi-Aventis Group, of Paris, and academic partner the Budapest University of Technology and Economics. The goal of the project, called KnowTox, is to build a new knowledge base related to hepatotoxicity, as well as related predictive tools to extend the value of the system. Financial specifics were not disclosed.
o Bioenvision Inc., of New York and Mayne Pharma Ltd., of Melbourne, Australia, entered a marketing and distribution agreement for the cancer product Evoltra (clofarabine). Bioenvision granted Mayne exclusive rights ...